High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis.

Puthenparampil M, Gaggiola M, Ponzano M, Zanotelli G, Miscioscia A, Nosadini M, Di Paola A, Sartori S, Perini P, Rinaldi F, Bovis F, Gallo P.